title: Therapeutic options for low bone mineral density in HIV-infected subjects.
abstract: With the advent of effective antiretroviral therapy (ART), the recognition and management of long-term complications of HIV infection and ART are increasingly important for HIV physicians. Low bone mineral density (BMD) is more common in those with HIV infection and this review will outline therapeutic options for the management of low bone mineral density relevant to HIV-infected populations.
authors.affiliation: HIV Molecular Research Group, University College Dublin, Clinical Research Centre, Nelson St., Dublin, Ireland. Aoife.cotter@ucdconnect.ie
authors.forename: Aoife G
authors.initials: AG
authors.lastname: Cotter
authors.forename: Patrick W G
authors.initials: PW
authors.lastname: Mallon
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects*; D050071:Bone Density Conservation Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*
chemical_list: D019380:Anti-HIV Agents; D050071:Bone Density Conservation Agents